Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abbott Laboratories (ABT) vs Upwork Inc (UPWK) Price & Performance

Abbott LaboratoriesTrade
Upwork IncTrade

Price performance (Past 24H)

Key statistics

Abbott Laboratories vs Upwork Inc — how do they compare? Abbott Laboratories trades at $111.14 (market cap $187.95B), while Upwork Inc trades at $8.24 (market cap $1.04B). The key difference: Abbott Laboratories is far larger — about 180.7× Upwork Inc's market cap, and Abbott Laboratories pays a 2.32% dividend while Upwork Inc pays none. Which is the better fit depends on your goals.

ABTUPWK
Market Cap
$187.95B$1.04B
Sector
HealthIndustrials
52-Week High
$136.62$22.11
52-Week Low
$82.57$7.84
Enterprise Value
$214.96B$806.15M
Dividend Yield
2.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abbott Laboratories

Abbott Laboratories (ABT) trades at $108.63, up 0.77% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages, though RSI indicates overbought conditions. Fundamentally, revenue grew to $44.33B in 2025 with a net income margin of 11.65%, while recent Q1 and Q2 2026 earnings beat expectations. The company maintains solid cash flow from operations of $9.57B and recently secured CE Mark for innovative dual glucose-ketone sensors, reinforcing its healthcare leadership.

Outlook remains positive with a consensus price target of $120.70, implying 11% upside, supported by 75.6% analyst buy ratings. Key risks include competitive pressures in diagnostics and macroeconomic sensitivity. The dividend yield and innovation pipeline offer stability, but investors should monitor execution on growth initiatives amid evolving market conditions.

Upwork Inc

UPWK trades at $9.83, up 1.65% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 EPS of $0.41, beating expectations, but revenue guidance disappointed investors, causing a recent stock decline. Fundamentals show solid profitability with a 12.93% net income margin and attractive valuation ratios, including a P/E of 10.71. Cash flow from operations remains strong at $248.26 million for 2025.

The outlook is mixed: strong fundamentals and analyst buy ratings support upside potential, but weak guidance and active client declines pose near-term risks. Investment opportunity lies in valuation appeal and AI integration, balanced by execution challenges in a competitive freelance market.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Read more on ABT

About Upwork Inc

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.

Read more on UPWK